Melaka, Malaysia: Mahkota Medical Centre is reinforcing its reputation as one of Southeast Asia’s leading specialist healthcare providers by combining advanced medical technology, internationally accredited clinical standards, and patient-centred care to serve both local and international patients.
Located in the historic city of Melaka, the private hospital treats more than 300,000 patients annually, including over 95,000 international patients from Bangladesh, Indonesia, Singapore and other countries across the region. The hospital is supported by more than 200 specialist consultants across 47 medical specialties and has a capacity of 305 beds.
Mahkota Medical Centre has become an increasingly preferred destination for Bangladeshi patients seeking specialised treatment abroad. To simplify the medical journey, the hospital’s dedicated International Patient Services team assists patients with medical evaluations, appointment scheduling, treatment planning, travel arrangements, accommodation, interpreter services and post-treatment follow-up.
The hospital is accredited by the Joint Commission International (JCI), one of the world’s most recognised healthcare accreditation bodies. The certification reflects Mahkota’s commitment to maintaining international standards in patient safety, clinical quality, infection prevention, medication management and operational excellence.
Mahkota has established several Centres of Excellence covering Cancer Care, Orthopaedics, Neurosurgery, Spine Surgery, Kidney Care, Women’s Health, Minimally Invasive Surgery, Robotic-Assisted Surgery and Comprehensive Health Screening. Each centre adopts a multidisciplinary approach, enabling specialists from different fields to collaborate on personalised treatment plans.
Cancer care remains one of the hospital’s flagship services. Mahkota is recognised internationally through its Joint Commission International Clinical Care Program Certification (JCI-CCPC) for Breast Cancer. The certification acknowledges the hospital’s structured, evidence-based and patient-centred approach to cancer management.
Between August 2022 and February 2026, Mahkota’s Breast Cancer Clinical Care Program treated 262 patients, recording treatment completion rates of 89.9 percent for chemotherapy, 98.6 percent for radiotherapy and 94.4 percent for hormone therapy.
The hospital has also invested heavily in robotic-assisted surgery to improve surgical precision and patient outcomes. Among its latest technologies is the VELYSâĸ Robotic-Assisted Knee Replacement System, which enables surgeons to perform highly personalised knee replacement procedures with greater accuracy through real-time surgical planning and implant positioning.
In addition, Mahkota has introduced Japan’s hinotoriâĸ Robotic-Assisted Surgery System for minimally invasive procedures. The platform is currently used in specialties including Urology and Obstetrics & Gynecology. According to the hospital, 108 robotic-assisted surgeries have been successfully completed using the system, contributing to reduced blood loss, smaller incisions and faster recovery for patients.
Mahkota has further distinguished itself by becoming the first healthcare institution in Malaysia to receive JCI Clinical Care Program Certification for both Breast Cancer and Chronic Kidney Disease. The kidney disease programme offers long-term monitoring, specialist consultations, disease management and patient education. Since 2025, more than 120 patients have been enrolled in the programme.
The hospital has also expanded its expertise in kidney transplantation. Since 2020, Mahkota Medical Centre has successfully performed 12 kidney transplant procedures, reporting a 100 percent success rate. The transplant programme is supported by a multidisciplinary team of nephrologists, transplant surgeons, anaesthesiologists and specialised nursing staff.
As part of its digital transformation strategy, Mahkota has introduced a Smart Ward initiative integrating electronic medical records, bedside digital systems and real-time clinical information management. The technology is designed to improve communication among healthcare professionals, enhance operational efficiency and provide patients with a more responsive healthcare experience.
Hospital officials said Mahkota Medical Centre will continue investing in advanced medical technology, specialist expertise and internationally recognised quality standards to meet the growing demand for personalised healthcare. Through continuous innovation and comprehensive patient services, the hospital aims to further strengthen its position as one of Southeast Asia’s leading destinations for specialist medical treatment.
END/PR/01.07.2026
